Addressing Low Vaccination Rates: A National Health Priority

In response to alarmingly low vaccination rates among pregnant women utilizing state health services, Uruguayan public health authorities have launched a comprehensive, inter-institutional strategy to provide free respiratory syncytial virus (RSV) vaccinations.this initiative aims to significantly increase coverage and protect newborns from severe respiratory illnesses.

The RSV Threat and the Power of Maternal Vaccination

RSV poses a important threat to infants, particularly those under six months old, ofen leading to bronchiolitis and requiring intensive care. Data from the Centers for Disease Control and Prevention (CDC) shows that RSV is the most common cause of bronchiolitis and pneumonia in infants in the United States. Maternal vaccination offers a crucial defense. By vaccinating pregnant women, antibodies are transferred through the placenta, providing the fetus with vital protection against RSV from birth.

Immunizes the fetus through the placenta to improve the response to a respiratory picture of this virus.
Dr. Guillermo Velázquez, Easse Regional Directorate

Dr. Velázquez emphasizes the safety and efficacy of the vaccine, stating that it has very good references and has no described adverse effects.

Disparities in Vaccination Coverage Demand action

The urgency of this initiative stems from a stark disparity in vaccination coverage. While private healthcare providers in Maldonado have achieved approximately 90% coverage among pregnant users, the public sector’s coverage lagged significantly behind at less than 30% as of April. This discrepancy prompted immediate action to bridge the gap and ensure equitable access to preventative care.

At this rate, we do not achieve the goal of having between 85 and 90% coverage.
José gonzález, departmental director of Health by the MSP

A Multi-Faceted Approach to Boost Vaccination Rates

The inter-institutional plan, involving the Ministry of Public Health (MSP), the State Health Services Management (ASSE), and the Malm Milk Bank of Maldonado, is set to run until August 30th. The strategy focuses on raising awareness about the benefits of the RSV vaccine and facilitating access for pregnant women in both the public and private sectors.

Accessing the RSV Vaccine: Streamlined and Accessible

the Regional Bank of Milk Milk of the HEMOCENTRO is proactively contacting potential recipients to schedule vaccinations and provide comprehensive information. This outreach is facilitated through a specialized interaction system, working in collaboration with public and private health centers.

Multiple Options for Vaccination

Recognizing the diverse needs of pregnant women, the program offers several convenient options for vaccination:

• Scheduling an appointment at a nearby vaccination center.
• Requesting a home visit for vaccination, particularly beneficial for those with mobility challenges.
• consulting with their doctor or healthcare provider before making a decision.

Furthermore, pregnant women can receive the vaccine at any health institution with vaccination services, including municipal polyclinics, regardless of their healthcare provider affiliation. The vaccine is provided free of charge.

Combating Misinformation with scientific Evidence

A key component of the strategy involves addressing misinformation and dispelling myths surrounding the RSV vaccine.Public health officials emphasize the importance of relying on credible sources and consulting with healthcare professionals for accurate information.

We think among all the necessary strategies to encourage pregnant women to vaccinate,knock down myths and increase coverage.We do it with scientific evidence and a clear objective: protect newborns and their families.
Dr. Alejandra Paulo, director of the Primary Care Network (rap) of ASSE

This initiative aims to ensure that 100% of pregnant women received the information about the vaccine, which is endorsed by leading medical organizations and backed by robust scientific evidence.